K. Murray Christopher's most recent trade in Blueprint Medicines Corp was a trade of 2,521 Common Stock done at an average price of $90.7 . Disclosure was reported to the exchange on March 7, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 07 Mar 2024 | 2,521 | 33,853 (0%) | 0% | 90.7 | 228,629 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 01 Mar 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 01 Mar 2024 | 12,500 | 36,995 (0%) | 0% | 0 | Common Stock | ||
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 01 Mar 2024 | 621 | 36,374 (0%) | 0% | 93.7 | 58,157 | Common Stock | |
| Blueprint Medicines Corp | K. Christopher Murray | CHIEF TECHNICAL OPERATIONS | 28 Feb 2024 | 5,000 | 8,000 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | K. Murray Christopher | CHIEF TECHNICAL OPERATIONS | 28 Feb 2024 | 5,000 | 24,495 (0%) | 0% | 100 | 500,000 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 28 Feb 2024 | 5,000 | 29,495 (0%) | 0% | 54.1 | 270,650 | Common Stock | |
| Blueprint Medicines Corp | Christopher Murray K. | CHIEF TECHNICAL OPERATIONS | 07 Dec 2023 | 5,000 | 13,000 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | K. Christopher Murray | CHIEF TECHNICAL OPERATIONS | 07 Dec 2023 | 5,000 | 29,495 (0%) | 0% | 54.1 | 270,650 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 07 Dec 2023 | 5,000 | 24,495 (0%) | 0% | 75 | 375,000 | Common Stock | |
| Blueprint Medicines Corp | K. Christopher Murray | CHIEF TECHNICAL OPERATIONS | 04 Dec 2023 | 600 | 24,495 (0%) | 0% | 71.4 | 42,858 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 26 Oct 2023 | 600 | 25,095 (0%) | 0% | 56.4 | 33,840 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 06 Mar 2023 | 1,829 | 25,741 (0%) | 0% | 45.7 | 83,604 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 06 Mar 2023 | 46 | 25,695 (0%) | 0% | 44.3 | 2,038 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 01 Mar 2023 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Christopher K. Murray | CHIEF TECHNICAL OPERATIONS | 01 Mar 2023 | 8,750 | 27,570 (0%) | 0% | 0 | Common Stock | ||
| Blueprint Medicines Corp | Christopher K. Murray | SVP, TECHNICAL OPERATIONS | 04 Aug 2022 | 2,500 | 18,820 (0%) | 0% | 65 | 162,500 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | SVP, TECHNICAL OPERATIONS | 04 Aug 2022 | 2,500 | 21,320 (0%) | 0% | 60.4 | 151,100 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | SVP, TECHNICAL OPERATIONS | 03 Mar 2022 | 1,066 | 24,322 (0%) | 0% | 60.3 | 64,248 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | SVP, TECHNICAL OPERATIONS | 03 Mar 2022 | 502 | 23,820 (0%) | 0% | 56.2 | 28,207 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | SVP, TECHNICAL OPERATIONS | 01 Mar 2022 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Christopher K. Murray | SVP, TECHNICAL OPERATIONS | 01 Mar 2022 | 6,500 | 25,388 (0%) | 0% | 0 | Common Stock | ||
| Blueprint Medicines Corp | Christopher K. Murray | SVP, Technical Operations | 04 Mar 2021 | 1,133 | 18,888 (0%) | 0% | 86.6 | 98,129 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | SVP, Technical Operations | 04 Mar 2021 | 77 | 20,021 (0%) | 0% | 89.0 | 6,855 | Common Stock | |
| Blueprint Medicines Corp | Christopher K. Murray | SVP, Technical Operations | 01 Mar 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Christopher K. Murray | SVP, Technical Operations | 01 Mar 2021 | 6,250 | 20,098 (0%) | 0% | 0 | Common Stock |